Sexual health outcomes among adolescent and young adult cancer patients: a systematic review and meta-analysis.
Journal
JNCI cancer spectrum
ISSN: 2515-5091
Titre abrégé: JNCI Cancer Spectr
Pays: England
ID NLM: 101721827
Informations de publication
Date de publication:
31 Oct 2023
31 Oct 2023
Historique:
received:
11
07
2023
revised:
08
09
2023
accepted:
12
09
2023
medline:
27
11
2023
pubmed:
25
10
2023
entrez:
25
10
2023
Statut:
ppublish
Résumé
Sexual health outcomes (SHO), which entail the physical, emotional, mental, and social impacts, are an important consideration for adolescent and young adults (AYA, ages 15-39) affected by cancer. The objective of this systematic review and meta-analysis is to summarize the current literature and evaluate AYA cancer impact on SHO. EMBASE and MEDLINE were searched from January 1, 2000 to September 28, 2022 to identify epidemiologic studies that used an analytic observational design, included individuals with AYA cancer and non-cancer control participants, and evaluated SHO. Odds ratios and prevalence ratios were calculated; random effects models were used to obtain pooled measures where possible. Of 2621 articles, 8 were included that investigated 23 SHO in 9038 AYA cancer patients. Based on the sexual response cycle, outcomes were categorized as those occurring among males (desire = 1, arousal = 1, orgasm = 4, other = 3) and females (desire = 2, arousal = 1, orgasm = 2, pain = 6, other = 3). It was feasible to conduct meta-analysis for 3 female SHO and 5 male SHO. There were associations between AYA cancer and 3 SHO: vaginal dryness (pooled odds ratio = 3.94; 95% confidence interval (CI) = 2.02 to 7.70), ejaculatory dysfunction (pooled odds ratio = 3.66; 95% CI = 2.20 to 6.08), and testosterone level (pooled mean difference = -2.56 nmol/liter; 95% CI = -3.46 to -1.66; P = .00001). This study found increased ejaculatory dysfunction and reduced testosterone levels in male AYA cancer patients and increased vaginal dryness in female AYA cancer patients, highlighting the need for sexual health resources in this population.
Sections du résumé
BACKGROUND
BACKGROUND
Sexual health outcomes (SHO), which entail the physical, emotional, mental, and social impacts, are an important consideration for adolescent and young adults (AYA, ages 15-39) affected by cancer. The objective of this systematic review and meta-analysis is to summarize the current literature and evaluate AYA cancer impact on SHO.
METHODS
METHODS
EMBASE and MEDLINE were searched from January 1, 2000 to September 28, 2022 to identify epidemiologic studies that used an analytic observational design, included individuals with AYA cancer and non-cancer control participants, and evaluated SHO. Odds ratios and prevalence ratios were calculated; random effects models were used to obtain pooled measures where possible.
RESULTS
RESULTS
Of 2621 articles, 8 were included that investigated 23 SHO in 9038 AYA cancer patients. Based on the sexual response cycle, outcomes were categorized as those occurring among males (desire = 1, arousal = 1, orgasm = 4, other = 3) and females (desire = 2, arousal = 1, orgasm = 2, pain = 6, other = 3). It was feasible to conduct meta-analysis for 3 female SHO and 5 male SHO. There were associations between AYA cancer and 3 SHO: vaginal dryness (pooled odds ratio = 3.94; 95% confidence interval (CI) = 2.02 to 7.70), ejaculatory dysfunction (pooled odds ratio = 3.66; 95% CI = 2.20 to 6.08), and testosterone level (pooled mean difference = -2.56 nmol/liter; 95% CI = -3.46 to -1.66; P = .00001).
CONCLUSION
CONCLUSIONS
This study found increased ejaculatory dysfunction and reduced testosterone levels in male AYA cancer patients and increased vaginal dryness in female AYA cancer patients, highlighting the need for sexual health resources in this population.
Identifiants
pubmed: 37878813
pii: 7329727
doi: 10.1093/jncics/pkad087
pmc: PMC10674049
pii:
doi:
Substances chimiques
Testosterone
3XMK78S47O
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press.
Références
Evid Rep Technol Assess (Full Rep). 2012 Aug;(208.3):1-475
pubmed: 24422952
J Adolesc Young Adult Oncol. 2017 Jun;6(2):377-380
pubmed: 28112547
J Clin Oncol. 2018 Jul 20;36(21):2169-2180
pubmed: 29874135
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Eur Urol. 2007 Nov;52(5):1438-47
pubmed: 17350159
Support Care Cancer. 2013 Jan;21(1):271-80
pubmed: 22714701
J Clin Oncol. 2020 Sep 20;38(27):3161-3174
pubmed: 32673152
Support Care Cancer. 2010 Jun;18(6):659-65
pubmed: 20237806
Hematology Am Soc Hematol Educ Program. 2005;:523-7
pubmed: 16304430
J Sex Med. 2014 Feb;11(2):595-604
pubmed: 24286464
BMC Public Health. 2013 Feb 19;13:154
pubmed: 23421987
CA Cancer J Clin. 2021 May;71(3):250-263
pubmed: 33283888
Psychooncology. 2018 Jul;27(7):1802-1809
pubmed: 29644783
Psychol Health Med. 2008 May;13(3):313-25
pubmed: 18569899
JAMA Netw Open. 2020 Dec 1;3(12):e2027738
pubmed: 33258907
Psychooncology. 2019 Apr;28(4):675-686
pubmed: 30703261
J Cancer Surviv. 2018 Aug;12(4):450-459
pubmed: 29508213
J Cancer Surviv. 2018 Feb;12(1):47-63
pubmed: 28988393
Oncologist. 2014 Feb;19(2):202-10
pubmed: 24396051
J Androl. 2012 Sep-Oct;33(5):886-93
pubmed: 21474790
JAMA Netw Open. 2020 Mar 2;3(3):e201965
pubmed: 32202640
J Clin Endocrinol Metab. 2007 Sep;92(9):3476-82
pubmed: 17579201
J Cancer Surviv. 2016 Oct;10(5):814-31
pubmed: 26920873
Fertil Steril. 2011 May;95(6):1922-7, 1927.e1
pubmed: 21376314
J Pediatr Oncol Nurs. 2017 Jul/Aug;34(4):295-308
pubmed: 28615000
Gynecol Oncol. 2012 Mar;124(3):477-89
pubmed: 22134375
Endocr Rev. 2019 Jun 1;40(3):711-767
pubmed: 30476004
World Psychiatry. 2016 Oct;15(3):205-221
pubmed: 27717275
Front Endocrinol (Lausanne). 2019 Apr 02;10:196
pubmed: 31001201
Cult Health Sex. 2022 Oct;24(10):1319-1335
pubmed: 34657546
Oncology. 2018;94(4):200-206
pubmed: 29393227